Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...

Vertex Pharmaceuticals Incorporated (NASDAQ ... Additionally, while Vertex's CF franchise remains robust, the company must successfully expand into new therapeutic areas to maintain its growth ...

Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

Walter Kimble has opened his own Seniors Helping Seniors franchise in Philadelphia with ... as director of global procurement at the Big Pharma company's West Point campus in Montgomery County ...

Novo’s booming semaglutide franchise for diabetes and obesity ... Novo is among several pharma companies and other business entities challenging the IRA in court although largely in vain so ...

CEO Bill Sibold hailed 2024 as a "transformational year" for Madrigal Pharmaceuticals, but Wall Street isn't as enthusiastic about the company's sales results. CEO Bill Sibold hailed 2024 as a ...